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A B S T R A C T   
Isoniazid (INH) is one of the two most effective first-line antitubercular drugs and is still used at the present time 
as a scaffold for developing new compounds to fight TB. In a previous study, we have observed that an INH 
derivative, an hydrazide N′-substituted with a C10acyl chain, was able to counterbalance its smaller reactivity 
with a higher membrane permeability. This resulted in an improved performance against the most prevalent 
Mycobacterium tuberculosis (Mtb) resistant strain (S315T), compared to INH. In this work, we have designed two 
new series of INH derivatives (alkyl hydrazides and hydrazones) with promising in silico properties, namely 
membrane permeabilities and spontaneous IN* radical formation. The kinetics, cytotoxicity, and biological ac-
tivity evaluations confirmed the in silico predictions regarding the very high reactivity of the alkyl hydrazides. 
The hydrazones, on the other hand, showed very similar behavior compared to INH, particularly in biological 
tests that take longer to complete, indicating that these compounds are being hydrolyzed back to INH. Despite 
their improved membrane permeabilities, the reactivities of these two series are too high, impairing their overall 
performance. Nevertheless, the systematic data gathered about these compounds have showed us the need to find 
a balance between lipophilicity and reactivity, which is paramount to devise better INH-based derivatives aimed 
at circumventing Mtb resistance.   
1. Introduction 
Tuberculosis (TB) is still one of the most deadly infectious diseases 
and about 25% of the global population is infected with Mycobacterium 
tuberculosis (Mtb), the causative agent of TB. Yet, TB is a largely pre-
ventable and treatable disease. The last World Health Organization 
(WHO) report on TB [1] estimated in 2019 the occurrence of 10 million 
new cases worldwide and about 1.4 million deaths. Additionally, about 
half a million people developed rifampicin (RIF)-resistant TB, of which 
78% corresponded to multidrug-resistant tuberculosis, a form of TB that 
does not respond to at least the two most powerful first-line antituber-
cular drugs, RIF and isoniazid (INH). To make the scenario worse, a very 
recent media brief from STOP TB Partnership [2] recognized the 
dramatic impact of COVID-19 pandemic on TB, particularly in low- and 
middle-income countries, due to an enormous decline in TB diagnosis 
and treatment (a 23% decrease for nine of the high-TB burden coun-
tries). This is aggravated by an increased risk of adverse outcomes and 
mortality (3 times higher in people co-infected with SARS-CoV-2) [2]. 
Isoniazid (INH) is active solely against mycobacteria, in particular 
Mtb, with minimum inhibitory concentrations ranging from 0.02 to 0.1 
μg/mL, and it penetrates the mycobacterial cell through passive diffu-
sion [3]. INH is a prodrug that needs to be converted to its active form by 
the multifunctional catalase-peroxidase enzyme KatG. Once activated, 
INH forms an isonicotinoyl radical that binds to nicotinamide adenine 
dinucleotide (NAD+), ultimately forming the IN-NAD adduct. IN-NAD 
binds and inactivates InhA, an NADH-dependent enoyl-acyl carrier 
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protein reductase essential for mycolic acid biosynthesis [4]. As mycolic 
acids are essential constituents of the Mtb cell wall, this is the ultimate 
target of INH [5]. KatG-dependent activation of INH and subsequent 
inactivation of InhA results in an accumulation of long chains of fatty 
acids, inhibition of biosynthesis of mycolic acids, and loss of acid fast-
ness. Consequently, the cell’s surface wrinkles and bulges resulting in a 
deformed and swollen rod that ultimately bursts [3,5]. Isoniazid resis-
tance is associated with a multiplicity of mutations affecting one or more 
genes, mainly, the genes katG and inhA. In clinical isolates of Mtb, the 
great majority of the mutations responsible for INH resistance occur in 
the katG gene, where the presence of repeated sequences makes it prone 
to high-level resistance mutations. The most common one is at codon 
315, where a serine is substituted by a threonine (i.e., S315T KatG). 
Mutations in other genes also decrease affinity towards INH, especially 
the mutations in the inhA gene, resulting in the incapacity of INH (and 
ethionamide) to inhibit the mycolic acid synthesis, conferring low-level 
resistance (except when a combination of mutations in katG and in the 
inhA promoter region occur) [3]. Being one of the two most effective 
drugs of the standard anti-TB treatment regimen, resistance to INH, at 
any level, poses serious difficulties in the management of TB. Over-
coming resistance towards INH is, therefore, a major challenge for drug 
discovery and new therapeutic regimens for TB include either the 
improvement of the therapeutic efficacy of INH or the search for syn-
ergistic effects in combination with other drugs [6]. 
In our previous work, we have devised a two-step computational 
protocol to generically estimate the stability and membrane perme-
ability of INH derivatives [7]. In the first step, we used Quantum Me-
chanics (QM) calculations to estimate the reactivity of INH derivatives 
to spontaneously form the IN•radical. Membrane permeabilities were 
calculated using Molecular Dynamics (MD) simulations coupled with 
the umbrella sampling/potential of mean force protocols. Interestingly, 
KatG kinetics and minimum inhibitory concentration (MIC) values ob-
tained for INH and their acylated derivatives could only be interpreted 
using a trade-off between the compounds’ reactivity and membrane 
trafficking ability. Indeed, we observed that the acyl hydrazide INH-C10 
counterbalances a significantly smaller reactivity by having a higher 
membrane permeability. 
Based on our previous results, in this study, we aimed to design a new 
series of compounds that combine a high membrane permeability with 
reactivity to spontaneously form the IN• radical that is similar to or 
better than INH. These new compounds were designed and initially 
tested in silico before their synthesis and subsequent assessment by in 
vitro KatG kinetics, as well as cytotoxicity and biological evaluation. 
2. Methods 
2.1. Quantum mechanics calculations 
Quantum mechanical (QM) calculations were used to estimate the 
Gibbs free energies of formation, ΔG, following a previously described 
approach [7]. The reactions for the spontaneous activation of INH and 
its derivatives (Fig. 1) can be arranged in thermodynamic cycles to 
simplify the number of calculations needed: 
ΔGINH = G(IN*) + G(H+) + G(e− ) + G(N2H2) – G(INH). 
ΔGINH− X = G(IN*) + G(H+) + G(e− ) + G(N2X) – G(INH-X). 
ΔΔG = ΔGINH− X – ΔGINH = G(N2X) – G(INH-X) – G(N2H2) + G(INH). 
Following the proposed scheme, calculation of the Gibbs free energy 
of formation requires estimation of the free energies of H2N2, N2X, INH, 
and INH-X. The mechanism assumes that a homolytic cleavage of the 
–(C–O)–NHN– bond occurs to form an isonicotinoyl radical (IN*), 
H2N2/N2X, a proton, and an electron. This mechanism is slightly 
different in the case of the imine compound series (INH-iCn). It is 
assumed that deprotonation still occurs, leading to the formation of IN* 
and the N− –N+–CH–R compounds, which were used in the calcula-
tions. All QM calculations were performed at the density functional 
theory (DFT) level with the M06 functional [8] and the aug-ccpVDZ 
Dunning basis sets [9,10] The SMD implicit solvent model was used 
with the QM calculations [11]. These settings were also used in the QM 
geometry optimizations to prepare the different compounds for force 
field parameterization. 
2.2. Molecular dynamics simulations 
MD simulations coupled to steered MD and Umbrella Sampling 
protocols were performed to calculate in silico the membrane perme-
abilities of the INH derivatives. The protocol was similar for all systems. 
The membrane was modeled by a pre-equilibrated slab of 128 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipids with 5941 
water molecules [7,12,13]. The simulations were performed using 
GROMACS 2018.6 [14] and the GROMOS 54A7 force field [15,16]. 
Water molecules were described with the SPC water model [17]. The 
topologies were determined using the Automated Topology Builder 
(ATB) and Repository [18] and manually curated [19–21]. In particular, 
the ATB topologies were modified in the pairs section to exclude 1–4 
interactions in the pyridyl fragment, following the GROMOS rules for 
aromatic rings. In the series of compounds with varying lengths of the 
aliphatic chain, the topologies were built for the shortest chain com-
pound and propagated with additional methylene groups to fulfill the 
desired length. This approach favors parameter transferability and al-
lows a more unbiased comparison between analogous compounds. 
All simulations were performed within the NPT ensemble with the 
pressure (1 bar with a coupling constant of 2 ps) and temperature 
(298.15 K with a coupling constant of 0.1 ps) being kept constant using 
the Parrinello–Rahman barostat [22,23] and v-rescale thermostat [24], 
respectively. Semi-isotropic pressure coupling was used with the 
compressibility of 4.5 × 10− 5 bar− 1. The particle mesh Ewald method 
was used for the electrostatic interactions with a real-space cutoff of 
1.0 nm and a Fourier grid spacing of 0.12 nm. van der Waals in-
teractions were truncated above 1.0 nm. All bonds were constrained 
using the P-LINCS algorithm [25] for membrane and solutes, and 
SETTLE [26] for water. The equations of motion were integrated every 
Fig. 1. Reactional scheme with products obtained from spontaneous activation 
of INH and its acyl, imine and alkyl derivatives. The R group stands for an 
aliphatic tail and n in the Cn suffix stands for the number of carbon atoms in the 
substituents. For a complete list of compounds used in this work, please 
see Table 1. 
C.F. de Faria et al.                                                                                                                                                                                                                              
Biomedicine & Pharmacotherapy 144 (2021) 112362
3
2 fs with the neighbor lists being updated every 10 steps. 
All starting systems were energy minimized to remove unfavorable 
interactions. In the minimization step, both the steepest descent and 
low-memory Broyden–Fletcher–Goldfarb–Shanno algorithms were 
used. The initialization was performed in two steps of 100 ps each: the 
first was performed at constant volume and the second with a temper-
ature coupling constant of 0.01 ps to avoid large fluctuations. The 
different compounds were pulled across the lipid bilayer (at 10 nm ns− 1 
with a force constant of 1000 kJ mol− 1 nm− 2) in a steered MD protocol 
to generate starting conformations for the US protocol. In this scheme, 
equally spaced umbrella windows (in intervals of 0.1 nm) ranging from 
the center of the bilayer (0 nm) to a distance of 3.5 nm (zero energy 
setting) were selected, corresponding to bulk water. Each umbrella was 
run for 150 ns (shorter chains) or 250 ns (longer chains) and the initial 
20 ns were discarded in the potential of mean force (PMF) calculation to 
ensure convergence. The compounds were restrained using a bias force 
constant of 1000 kJ mol− 1 nm− 2 centered in the N′ atom. The weighted 
histogram analysis method (WHAM) [27] was used for the PMF calcu-
lations. The permeability rates were calculated using the inhomoge-
neous solubility-diffusion model (ISDM) [28,29] coupled to the biasing 
harmonic potential [30,31]. The error values (standard error of the 
mean) were calculated from two segments obtained by splitting the 
converged data into two halves, which were treated as independent. 
3. Results and discussion 
3.1. Proposal of new INH-derivatives with improved reactivities and 
membrane permeabilities 
We have previously devised a strategy based on a thermodynamic 
cycle to estimate the Gibbs free energies of formation of the IN* radical 
starting from different prodrug compounds [7]. With this approach, we 
observed that two acylated INH derivatives (INH-C2 and INH-C10) were 
significantly deactivated, which could explain their lower experimental 
activities against wt-KatG. However, low MIC values were obtained for 
INH-C10, especially in S315T mutated strains, which we attributed to an 
improved diffusion across cell membranes as compared with INH [7]. In 
this work, we have systematically calculated the reactivity of these INH 
acylated derivatives which included those not covered in our previous 
work (C4 – C8) (Fig. 2). Overall, the free energies of formation are very 
similar for the complete acylated series (Table 1), confirming that all 
compounds are very stable. In our previous work, due to a small error in 
our procedure, the membrane permeabilities reported for INH, INH-C2, 
and INH-C10 [7] were erroneously multiplied by a factor of 2. Even 
though this did not affect the relative quantitative interpretation of the 
data, we decided to include those compounds also in this study, which 
follows a protocol that benefits from longer simulations, hence better 
sampling. The membrane permeabilities of the acylated series showed a 
gradual increase with the size of the aliphatic chain (Table 1). Excluding 
INH-C2, all other acylated compounds have improved membrane per-
meabilities as compared with INH, which indicates that the improved 
MIC values observed for INH-C10, compared to INH-C2 [32], could have 
also been obtained, at least partially, for other shorter chain compounds 
like INH-C8 or INH-C6. 
The results obtained with the acyl hydrazide series provided the 
starting point for the design of two new series of INH derivatives (Fig. 2), 
aiming at having similar or better reactivity profiles than INH while 
retaining improved membrane permeabilities like INH-C10. The ratio-
nale was to modify the acyl moiety, which, being electron-withdrawing, 
weakens the N–N bond and, consequently, strengthens the adjacent 
amide bond, precisely the one that needs to be cleaved for IN* forma-
tion. With this in mind, and based on the acyl hydrazide scaffold, two 
homologous series of INH derivatives were designed: the hydrazone 
series (INH-iCn), where the N′ atom, instead of participating in an amide 
function, becomes part of a hydrazone moiety, and the N′-alkyl hydra-
zide (INH-aCn) series, where the N′ carbonyl group is deoxygenated (see 
Fig. 2. Chemical structure of INH and each of its three derivative series studied in this work.  
Table 1 
Isonicotinoyl radical Gibbs free energies of formation, and membrane perme-
abilities for INH and all its derivatives used in this work (see their chemical 
structures in Fig. 2). The ΔΔG values for INH, INH-C2, and INH-C10 were ob-
tained from our previous work [7]. Even though we cannot estimate error values 
for the ΔΔG presented here, as a rule of thumb, we can assume at least 
2 kcal/mol for most computational protocols. Please note that the membrane 
permeabilities of INH, INH-C2, and INH-C10 were calculated incorrectly in our 
previous work (values were wrongly multiplied by 2) [7], and therefore they 
were recalculated using our protocol with improved sampling.  
Compound Number ΔΔG (kcal/mol) Permeability (cm s− 1) ± s.e. 
INH – 0.0 0.3 ± 0.1 
INH-C2 1a 9.1 0.5 ± 0.3 
INH-C4 1b 9.7 1.8 ± 0.1 
INH-C6 1c 8.9 2.2 ± 0.5 
INH-C8 1d 10.3 10.2 ± 2.1 
INH-C10 1e 10.8 12.1 ± 2.7 
INH-iC2 2a -1.3 1.8 ± 0.1 
INH-iC4 2b -1.3 2.5 ± 1.5 
INH-iC6 2c -1.7 9.4 ± 1.5 
INH-iC8 2d -2.8 10.5 ± 5.2 
INH-iC10 2e -2.4 24.3 ± 5.5 
INH-aC2 3a -6.8 0.5 ± 0.4 
INH-aC4 3b -9.1 3.3 ± 0.7 
INH-aC6 3c -9.8 5.5 ± 0.7 
INH-aC8 3d -10.4 16.5 ± 0.7 
INH-aC10 3e -10.5 29.2 ± 9.3  
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Fig. 2). The reactivities for the spontaneous formation of the IN* radical 
were calculated, using a probably unstable zwitterionic final compound 
as a reference. The hydrazone series showed reactivities similar to INH 
(Table 1) which, complemented with improved membrane permeabil-
ities (at least for the longer chains), can still lead to promising candidate 
compounds. The substitution of the N′-acyl group by an imino group 
produces an increase in the membrane permeabilities for a number of 
these new compounds. This higher permeability can be explained by a 
small reduction in the compounds’ polarity and a likely destabilizing 
effect on their first water solvation shell, which should decrease the 
desolvation penalties upon membrane insertion. On the other hand, the 
compounds belonging to the alkyl hydrazide series, INH-aCn showed 
free energies of formation ranging from − 6.8 to − 10.5 kcal/mol, for 
INH-aC2 to INH-aC10, respectively (Table 1). These ΔΔG values indicate 
that all these compounds should be very reactive, which was one of our 
objectives. They also show enhanced membrane permeabilities, which is 
particularly noticeable for the longer carbon chain compounds. 
In summary, we estimated in silico the spontaneous reactivities to-
wards isonicotinoyl radical formation of several INH derivatives, which 
allowed us to classify the compounds of the three designed series as 
deactivated (acyl hydrazide series, INH-Cn), INH-like activated (hydra-
zone series, INH-iCn), and extremely activated (alkyl hydrazide series, 
INH-aCn) molecules. The key factor influencing the reactivity seems to 
be the nature of the N′–C bond, whereas membrane permeability co-
efficients are mainly ruled by the length of the aliphatic carbon chain, 
resulting in similar permeability profiles independently of the N′
substitution. 
3.2. Synthesis and evaluation of the new INH derivatives 
We have previously studied the short (INH-C2) and long (INH-C10) 
chain acylated INH derivatives, which will be used in this work for 
comparative purposes. Several new INH derivatives from the two new 
series were synthesized in order to experimentally evaluate the 
computational results, namely a set of isonicotinoyl hydrazones derived 
from aliphatic aldehydes (hydrazone series), and another set corre-
sponding to their reduced counterparts, the N′-alkyl hydrazides (alkyl 
hydrazide series). 
The synthesis of the isonicotinoyl hydrazones was accomplished by a 
straightforward condensation of INH with commercially available al-
dehydes in ethanolic solution, under mild conditions. Reaction mixtures 
were maintained at room temperature for 24 h, leading to the corre-
sponding Schiff bases in yields ranging from 64.8% to 92.1%, after pu-
rification by recrystallization. These reactions were easy to accomplish 
unlike the formation of other imines due to the stabilizing isonicotinoyl 
moiety which reduces the electrophilic character of the imine carbon, 
preventing the back-reaction. All compounds were characterized using 
IR, 1H, 13C NMR, COSY, HMQC, HMBC, NOESY, and HR-MS. The details 
of spectral data are given in the experimental section and spectra are 
provided in Figs. S1–S18 of Supplementary material. 
In the NMR 1H spectra (DMSO-d6) of hydrazones (2a–2e), two sets of 
all protons were observed in a 1:0.1 ratio suggesting the presence of two 
species in solution. GC-MS and HPLC analyses of compounds established 
that, in all cases, only one isomer was present. We have previously re-
ported that isonicotinoyl hydrazones derived from aromatic aldehydes 
had (E) configuration around the C–N double bond and, in solution, 
existed mainly as the synperiplanar CO–NH conformation [32]. For the 
Schiff bases reported herein, the assignment of the C–N configuration 
was hampered by the overlapping of the pyridine H-3 proton signal with 
that of the imine, as both have space correlations with the NH proton. 
The chemical shifts often change with temperature since this property 
induces variations in the compound conformational space. Therefore, 
variable-temperature NMR can facilitate the resolution of peaks from 
different conformers when they are significantly overlapped. For com-
pound 2c, NMR experiments were recorded at 25, 40, 50, and 60 ◦C, and 
we found that the separation of the two signals was complete at 50 ◦C. 
We also performed a NOESY experiment at 50 ◦C and the expected more 
stable (E) configuration was confirmed by the strong cross-peak between 
the azomethine and the NH signals, only possible in this configuration. 
From the approaches reported in the literature to prepare hydrazides 
(3a–3e), the reduction of the corresponding Schiff bases is the most 
direct and versatile one, since it is accomplished in one step and takes 
advantage of the diversity allowed by several available aldehydes and 
ketones, which are useful to synthesize the hydrazones. Reduction of N′- 
acyl hydrazones may be achieved using sodium borohydride alone [33] 
or in combination with Amberlyst-15 (H+) [34], sodium cyanoborohy-
dride [35], or magnesium in methanol (MeOH) [36], among other 
reducing agents. All the mentioned methods were assayed, and we 
observed that the use of two equivalents of sodium cyanoborohydride, in 
refluxing methanol at pH 3, was the most suitable and selective pro-
cedure for the reduction of acyl hydrazones 2c–2e although affording 
poor yields. Despite the rigorous control of the medium’s pH, we could 
not circumvent over-reduction, which led to the N′,N′-dialkylated hy-
drazides as side products, probably through a mechanism analogous to 
the one observed for aldoximes [37]. 
In short, we have synthesized the complete hydrazone series (2a–2e) 
and several reduced derivatives from the alkyl hydrazide series (3c–3e) 
which were duly purified and characterized (see experimental). Stability 
assays carried out by UV–Vis, show that hydrazides are soluble and 
reasonably stable in 5% DMSO/water (> 90% remains after 24 h), 
whereas hydrazones decompose significantly within hours in the same 
conditions (e.g., 2d degrades ~ 30% after 1.5 h). Hydrazones are known 
to hydrolyze, and this process can be accelerated by higher temperature 
or lower pH values [38]. To confirm this hypothesis for our hydrazones, 
we carried out several stability UPLC-MS/MS experiments in water for 
compound 2c. In this case, the imine group hydrolyzed (~ 40% after 
5 min; ~ 60% after 20 h) and we recovered back the starting material, i. 
e., INH. 
KatG-induced kinetics of formazan formation using the nitroblue 
tetrazolium (NBT) assay, cytotoxicity towards HepG2 cells, MIC values 
against Mtb, as well as the therapeutic index (TI) taken as the ratio IC50/ 
MIC, are shown for many of these compounds in Table 2 (IC50 stands for 
the inhibitory concentration for 50% of the population). 
3.3. The alkyl hydrazide series (INH-aCn) 
Our computational studies indicate that the INH hydrazide de-
rivatives have a very high propensity to spontaneously form the IN* 
radical. This was confirmed by the kinetics experiments using the NBT 
assay where these compounds showed rates of formazan formation 
2–3× or 8–16× higher than INH for the KatG-catalyzed or uncatalyzed 
reaction, respectively (Table 2). Interestingly, in this series, the presence 
of KatG does not have an impact on the rate of radical formation, 
probably because the hydrazide uncatalyzed reaction is already signif-
icantly faster than the fastest KatG accelerated process observed (INH). 
Having compounds with such high reactivity can be advantageous, but it 
is not without caveats. A question remains regarding how stable/effec-
tive these compounds will be in the cellular environment: will the 
spontaneously formed radicals reach the desired target (NADH) to 
generate the IN-NAD adduct, or will they react with unspecified targets 
en route? Furthermore, if the uncatalyzed reaction was dominant, we 
would lose all specificity that is conferred by the protein activation step. 
Altogether, these limitations can make the alkyl hydrazides less effective 
and/or more cytotoxic. Our results do show that the N′-alkylated INH 
derivatives are indeed more cytotoxic than INH (Table 2). INH, a com-
pound known for its very low cytotoxicity (> 200 μM), contrasts with 
other approved antitubercular agents such as bedaquiline which has an 
IC50 of 17.4 μM [39]. Thus, a comparison of the IC50 values of the alkyl 
hydrazide derivatives with those of the aforementioned reference 
compounds indicates that the hydrazides may still be viable drugs. Here, 
their utility would depend on the trade-off (ratio) between cytotoxicity 
and MIC, usually quantified by the therapeutic index (TI) which is used 
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to estimate the therapeutic window of a drug and to identify drug can-
didates for further studies [40]. 
The measured MIC values against H37Rv for INH-aC6 and INH-aC10 
are 4 and 2 μM, respectively, which are approximately an order of 
magnitude higher than that determined for INH (Table 2). This lower 
performance in stopping the Mtb growth could suggest that (1) the 
spontaneously formed radical is only partially reaching the NADH 
target, or (2) none reaches the target, and the reaction is fully catalyzed 
by KatG. The latter hypothesis is corroborated by the MIC values 
observed for the ΔkatG mutant strain (⩾ 128 μM) (Table 2), which shows 
that KatG is pivotal in the activation of these compounds. Despite the 
weak overall performance, these two compounds show an uncommonly 
low minimum bactericidal concentration (MBC) against H37Rv (MBC =
64 and > 128 μM, respectively), suggesting a different mechanism of 
action that kills the mycobacteria instead of just preventing their 
growth, like in the case of INH (MBC = indeterminate) which is essen-
tially bacteriostatic. 
3.4. The hydrazone series (INH-iCn) 
The INH hydrazone derivatives showed in silico estimated reactivities 
similar to the reference compound, INH. In our kinetics experiments, the 
rates of formazan formation in the hydrazone series are about 3× slower 
than in INH, both in the presence and absence of KatG (Table 2). The 
rates of radical formation are slower than when using INH, which allows 
for a clear KatG-induced acceleration (~4×) for all hydrazone com-
pounds as also seen with INH. Despite the lower reactivities, compounds 
from this series can still benefit from improved membrane permeabil-
ities (Table 1) due to the presence of the lipophilic tails which improve 
the cell membrane crossing process, a phenomenon already observed for 
INH-C10 [7]. Their cytotoxicity values are also within the IC50 range 
observed for two compounds currently used in TB treatment, namely 
INH and bedaquiline, which make them relatively non-hepatotoxic. 
The MIC values for the two tested hydrazone compounds (INH-iC6 
and INH-iC10) are similar to that of INH for the wt strain (along with 
high values for the ΔkatG strain), which raise several scenarios: either 
(1) there is an unlikely perfect trade-off between the lower reactivities 
and the improved membrane permeabilities due to their higher lip-
ophilicity (logPO/W = 1.54 ± 0.08 and 2.9 ± 0.2, respectively vs. −
0.85 ± 0.01 for INH [42], where P O/W stands for the octanol-water 
partition coefficient); or (2) the hydrazone hydrolysis (recovering back 
INH) is occurring and is prevalent in a way that we are just measuring 
the effect of INH alone. The latter scenario seems more plausible as 
mentioned for compound 2d by UPLC-MS/MS where over 60% hydro-
lysis takes place after 20 h. This indicates that the hydrazone hydrolysis 
occurs in the experimental conditions of MIC evaluation (several days) 
but not in the kinetics experiments (only a few minutes), where we 
observed a lower reaction rate than with INH. Furthermore, this hy-
drolysis step must be significantly faster than the KatG-catalyzed acti-
vation, since otherwise, it would have had a detrimental effect on the 
observed MIC values. The indeterminate MBC behavior for these two 
hydrazones, which is the same as for INH, also supports the scenario of 
their complete hydrolysis within the duration of these experiments. 
Nevertheless, hydrazone hydrolysis could still be used as a strategy to 
release INH inside cells [43]. In this hypothetical drug-delivery system, 
the aliphatic tail increases the lipophilicity of this prodrug, hence 
increasing its bioavailability inside the target cells, while a slow hy-
drolysis step would revert the compound to its active form. In principle, 
such a system would lead to lower MIC concentrations than INH, due to 
the increased cell trafficking. However, since we obtained similar MIC 
values, the data suggests that hydrolysis is too fast, and we end up 
measuring the INH inherent activity in cells. The hydrazone hydrolysis, 
which was assessed by HPLC to be less than 24 h, still allowed the 
measurement of the hydrazone kinetics (within minutes), but fully 
compromised the results obtained from the MIC experiments, which 
took several days to complete. 
4. Conclusions 
We have devised two new series of INH derivatives that showed 
promising in silico properties. Both shared an aliphatic carbon chain with 
similar sizes as the acyl hydrazide series (INH-Cn), which we had pre-
viously characterized using INH-C2 and INH-C10 [7]. The rationale was 
the introduction of a long tail to improve the compound’s lipophilic 
character and, consequently, increase its membrane permeability, which 
we identified as the key factor behind the good performance of INH-C10. 
Our computational data indicated that substituting the N′ acyl chains by 
the corresponding alkyl (hydrazides; INH-aCn) or imine (hydrazones; 
INH-iCn) moieties leads to an activation of the C–N bond, which is 
required to break in order to produce the isonicotinoyl radical. To 
evaluate these predictions, we synthesized various compounds from 
both series and performed kinetics, cytotoxicity, and MIC experiments. 
The alkyl hydrazides showed impressively low energies in the QM 
calculations, suggesting a high reactivity towards the spontaneous 
radical formation. These results were confirmed in the stability and the 
NBT kinetic assays, where the compounds are decomposing, probably 
into the radical form, at a rate higher than the KatG-catalyzed reaction. 
However, the inferior performance in the MIC experiments, compared 
with INH, suggests that the higher number of radicals formed are not 
efficiently reaching NADH, which is their desired target inside the cells. 
On the other hand, compounds from the hydrazone series seem to be 
only slightly less reactive than INH. However, their possibly high hy-
drolysis rate may compromise their use in clinical settings, as suggested 
by the obtained MIC values, which can be attributed solely to INH, i.e., 
Table 2 
Rates of formazan formation (nM/s) by INH derivatives evaluated from the NBT assay in the presence and absence of KatG, the ratio between both rates, IC50 values 
(μM) against HepG2 cells, and MIC values (μM) against the wild-type Mtb (H37Rv) and against the H37RvINH (ΔkatG), a strain with full deletion of the katG gene. Also 
shown is the therapeutic index, TI.  
Cpds NBT assay with KatGa (nM/s) NBT assay 
w/out KatGa 
(nM/s) 
KatG factor Cyto-toxicity IC50 (μM)b Mtb H37Rv MIC (μM) TI IC50/MIC Mtb H37RvΔkatG MIC (μM) 
INH 6.8 ± 0.8 1.6 ± 0.5 4.3 > 200 0.3 [32] > 667 933.4 [41] 
INH-C2 2.8 ± 2.0 0.8 ± 0.8 3.5 – 44.7 [32] – > 55.8 [32] 
INH-C10 0.4 ± 0.2 0.6 ± 0.6 – > 25 0.5 > 50 > 34.3 [32] 
INH-aC6 22.3 ± 5.6 21.2 ± 18.0 1.1 39.8 4 10 > 128 
INH-aC8 15.2 ± 4.5 13.0 ± 9.2 1.2 23.2 – – – 
INH-aC10 20.6 ± 2.4 26.0 ± 17.0 0.8 48.0 2 24 128 
INH-iC4 2.1 ± 0.2 0.5 ± 0.2 4.2 > 200 – – – 
INH-iC6 – – – > 200 0.3 > 667 > 128 
INH-iC8 2.5 ± 1.0 0.6 ± 0.6 4.2 > 100 – – – 
INH-iC10 2.2 ± 0.4 0.5 ± 0.5 4.4 > 25 0.3 > 667 128  
a Values are average rates (nM/s) of two independent experiments with the range of the data representing the error. 
b Chlorpromazine was used as positive control (IC50 = 13.9 μM). 
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to the hydrolysis product. 
In conclusion, our data shows that the two new series of INH de-
rivatives are very reactive, in excellent agreement with our computa-
tional predictions. The alkyl hydrazides are probably too reactive, which 
appears to hinder their performance. This means that we could signifi-
cantly benefit from less activated alkyl groups that would better balance 
the rate of IN* formation with a higher bioavailability in the target cells. 
The high rate of hydrolysis of the hydrazone compounds is also masking 
this series results, especially the MIC measurements that require several 
days to complete. Nevertheless, the systematic nature of this work 
allowed us to pinpoint the key factors behind the chemical nature of the 
aliphatic groups used to increase INH lipophilicity and simultaneously 
to recognize the need for a compromise in terms of enhanced reactivity. 
This knowledge will be pivotal to devise even better INH derivatives 
aimed at improving MIC performance and circumvent Mtb resistance to 
INH. 
5. Experimental section 
5.1. Chemistry 
All organic solvents and reagents used throughout the procedures 
were purchased from commercial suppliers and used without additional 
purification. The course of the reactions was monitored by thin-layer 
chromatography performed on silica gel 60 F254 aluminum sheets 
(Ref. Merck 1.05554) and visualized with UV light at 254 nm. Flash 
column chromatography was performed on silica gel 60, 
0.04–0.063 mm, 230–400 mesh (Ref. Merck 1.09385). 1H NMR 
(400.1 MHz) and 13C NMR spectra (100.6 MHz) were recorded on a 
Bruker® Avance™ 400 spectrometer, using DMSO-d6 as solvent. 
Chemical shifts were expressed as δ (ppm) values and referenced to the 
residual solvent signal (δH = 2.50, δC = 39.51), coupling constants (J 
values) were reported in frequency units (Hz) and the following desig-
nations were used: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet). 1H and 13C assignments were made by 2D (COSY, HMQC, 
and HMBC) NMR experiments. The spectra treatment was performed 
using Bruker’s TopSpin™ 3.1 software. HR-ESI-MS analyses were ob-
tained on a hybrid quadrupole time-of-flight (QTOF) Bruker Impact II 
mass spectrometer at the IST node of the Portuguese Mass Spectrometry 
Network. IR spectra were recorded with 256 scans using Thermo Sci-
entific™ Nicolet 6700 FT-IR spectrometer, equipped with a beam 
splitter and only the diagnostic bands were reported in cm− 1. Sample 
pellets were prepared in an approximate concentration of 1 mg/100 mg 
KBr. 
The purity of all compounds (> 98%) was assessed by GC-MS anal-
ysis using Shimadzu® GCMS-QP2010 Plus, coupled with an autosampler 
AOC-20s, an automatic injector AOC-20i and a Teknokroma® Sapiens- 
5MS capillary column (30 m × 0.25 mm × 0.25 μm) packed with 
(95%) dimethyl (5%) diphenylpolysiloxane, and operating with an 
electron ionization (EI) source, using nitrogen as carrier gas at flow 
1 mL/min, at a pressure of 63 bar. Samples were prepared either in 
dichloromethane or methanol, in an approximate concentration of 
1 mg/mL, with one or more blanks of solvent being injected at the 
beginning of the analysis and between sample runs. Direct injection 
volume was 1 μL, at 280 ◦C; the GC oven was programmed at 100 ◦C 
(2 min), with a multi-step gradient temperature increase as follows: 
heated to 200 ◦C at 10 ◦C/min rate, then held at this temperature for 
2 min, further heated to 300 ◦C at 10 ◦C/min rate and held at final 
temperature for 15 min; the mass spectrometer operated at 250 ◦C. 
5.2. General procedure for the synthesis of isonicotinoyl hydrazones 
The compounds were synthesized according to optimized protocols 
previously reported [32]. Briefly, 1 equivalent aldehyde was added 
drop-by-drop to a solution of isoniazid heat-dissolved in absolute 
ethanol, and the mixture was kept under agitation at room temperature 
for 24 h. Butanal, hexanal, octanal and decanal were the chosen alde-
hydes. The solvent was then evaporated under reduced pressure, 
affording the Schiff bases as crude white solids, and further recrystal-
lized with ethyl acetate or acetone: MeOH 2:1 v/v to give crystalline 
white solids. 
5.2.1. N′-(E)-ethylideneisonicotinohydrazide 2a 
White crystals (recrystallization from dichloromethane/hexane) 
(η = 85%); IR (KBr), ν (cm− 1): 3232 (N–H amide), 3066 (arom. C–H), 
2980–2918 (aliph. C–H), 1653 (C–O amide), 1622 (C–N imine); 1H 
NMR (400 MHz, DMSO-d6), δ (ppm): 11.68 (s, 1H, NHC–O), 8.75 (d, 
2H, J = 4.7 Hz, H-2, H-6), 7.75 (m, 3H, H-3, H-5, H-1′), 1.94 (d, 3H, J =
5.2 Hz, H-2′); 13C NMR (100.6 MHz, DMSO-d6): δ (ppm) = 161.25 
(C–O), 150.32 (C-1′), 150.08 (C-2, C-6), 140.69 (C-4), 121.55 (C-3, C- 
5), 18.50 (C-2′). HR-ESI-MS: m/z 164.0822 [M + H]+ (calcd. for 
C8H9N3O + H, 164.0818). 
5.2.2. N′-(E)-butylideneisonicotinohydrazide 2b 
White crystals (recrystallization from ethyl acetate) (η = 64.8%); IR 
(KBr), ν (cm− 1): 3199 (N–H amide), 3069 (arom. C–H), 2932–2870 
(aliph. C–H), 1670 (C–O amide), 1633 (C–N imine); 1H NMR 
(400 MHz, DMSO-d6), δ (ppm): 11.65 (s, 1H, NHC–O), 8.75 (d, 2H, J =
4.7 Hz, H-2, H-6), 7.75 (m, 3H, H-3, H-5, H-1′), 2.26 (m, 2H, H-2′), 1.53 
(sext, 2H, J = 7.3Hz, H-3′), 0.93 (t, 3H, J = 7.3 Hz, H-4′); 13C NMR 
(100.6 MHz, DMSO-d6): δ (ppm) = 161.20 (C–O), 153.66 (C-1′), 
150.27 (C-2, C-6), 140.67 (C-4), 121.49 (C-3, C-5), 33.97 (C-2′), 19.37 
(C-3′), 13.65 (C-4′). HR-ESI-MS: m/z 192.1135 [M + H]+ (calcd. for 
C10H13N3O + H, 192.1131). 
5.2.3. N′-(E)-hexylideneisonicotinohydrazide 2c 
Amorphous white powder (η = 81%); IR (KBr), ν (cm− 1) = 3230 
(N–H amide), 3069 (arom. C–H), 2951–2868 (aliph. C–H), 1646 
(C–O amide), 1625 (C–N imine); 1H NMR (500 MHz, DMSO-d6), δ 
(ppm): 11.65 (s, 1H, NHC–O), 8.75 (d,d, 2H, J = 4.5; 1.5 Hz, H-2, H-6), 
7.78 (t, 1H, J = 5; H-1′), 7.75 (d, 2H, J = 4.3; H-3, H-5), 2.27 (dt, 2H, J =
7.3; 5.7 Hz, H-2′), 1.50 (quint, J = 7.3; Hz H-3′), 1.31 (m, 4H, H-4′, H- 
5′), 0.88 (t, 3H, H-6′); 13C NMR (100.6 MHz, DMSO-d6), δ (ppm): 161.24 
(C–O), 153.84 (C-1′), 150.28 (C-2, C-6), 140.67 (C-4), 121.51 (C-3, C- 
5), 32.00 (C-2′), 30.90 (C-4′), 25.65 (C-3′), 21.94 (C-5′), 13.92 (C-6′). 
HR-ESI-MS: m/z 220.1447 [M + H]+ (calcd. for C12H17N3O + H, 
220.1444). 
5.2.4. N′-(E)-octylideneisonicotinohydrazide 2d 
White crystals (recrystallization from ethyl acetate) (η = 73.2%); IR 
(KBr), ν (cm− 1): 3204 (N–H amide), 3068 (arom. C–H), 2922–2854 
(aliph. C–H), 1655 (C–O amide), 1624 (C–N imine); 1H NMR 
(400 MHz, DMSO-d6), δ (ppm): 11.64 (s, 1H, NHC–O), 8.74 (d, 2H, J =
4.6 Hz, H-2, H-6), 7.74 (m, 3H, H-3, H-5, H-1′), 2.26 (m, 2H, H-2′), 1.49 
(m, 2H, H-3′), 1.27 (m, 8H, H-4′ to H-7′), 0.86 (t, 3H, H-8′); 13C NMR 
(100.6 MHz, DMSO-d6): δ (ppm) = 161.23 (C–O), 153.85 (C-1′), 
150.27 (C-2, C-6), 140.66 (C-4), 121.50 (C-3, C-5), 32.02 (C-2′), 31.22 
(C-6′), 28.64, 28.51 (C-4′, C-5′), 25.97 (C-3′), 22.10 (C-7′), 13.98 (C-8′). 
HR-ESI-MS: m/z 248.1762 [M + H]+ (calcd. for C14H21N3O + H, 
248.1754). 
5.2.5. N′-(E)-decylideneisonicotinohydrazide 2e 
White crystals (recrystallization from ethyl acetate) (η = 92.1%); IR 
(KBr), ν (cm− 1): 3254 (N–H amide), 3075 (arom. C–H), 2925–2849 
(aliph. C–H), 1655 (C–O amide), 1625 (C–N imine); 1H NMR 
(400 MHz, DMSO-d6), δ (ppm): 11.64 (s, 1H, NHC–O), 8.75 (d, 2H, J =
4.8 Hz, H-2, H-6), 7.75 (m, 3H, H-3, H-5, H-1′), 2.26 (q, 2H, J = 6.7 Hz 
H-2′), 1.49 (m, 2H, H-3′), 1.25 (m, 10H, H-4′ to H-9′), 0.85 (t, 3H, H-10′); 
13C NMR (100.6 MHz, DMSO-d6): δ (ppm) = 161.23 (C–O), 153.85 (C- 
1′), 150.27 (C-2, C-6), 140.67 (C-4), 121.50 (C-3, C-5), 32.02 (C-2′), 
31.22 (C-8′), 28.95, 28.85, 28.72, 28.68 (C-4′ to C-7′), 25.96 (C-3′), 
22.13 (C-9′), 14.00 (C-10). HR-ESI-MS: m/z 276.2075 [M + H]+ (calcd. 
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for C16H25N3O + H, 276.2070). 
5.3. General procedure for the synthesis of isonicotinoyl hydrazides [35] 
Given the QM and MD results, just the most promising members of 
the series were synthesized, i.e., compounds 3c–3e, as follows: two 
equivalents of NaBH3CN were added portion-wise to a solution of the 
parent hydrazone in methanol. Methanolic HCl 5 M was then progres-
sively added until reaching pH 3, evidenced by a strong color change to 
dark yellow. The mixture was kept under reflux and agitation for several 
hours until the reaction was complete. Methanol was then evaporated 
under reduced pressure, giving an orange-yellow oil, to which a work-up 
procedure [adapted from [37]] was applied as follows: after the disso-
lution of the residue in water, a few drops of NaOH 6 M were added to 
basify the solution to pH > 7, destroying the possible cyanoborate ad-
ducts; after addition of brine, the solution was extracted several times 
with dichloromethane, the combined organic extracts were dried with 
MgSO4 and the solvent evaporated under reduced pressure, affording 
crude yellowish solids which were further purified by column chroma-
tography. White powders were then obtained and washed with hexane 
to remove small amounts of impurities. 
5.3.1. N′-hexylisonicotinohydrazide 3c 
Amorphous white powder (column chromatography with Et2O: 
MeOH 98.2) η = 27.4%; IR (KBr): ν (cm− 1) = 3333 (N–H amide), 3018 
(arom. C–H), 3000–2850 (aliph. C–H), 1635 (C–O amide); 1H NMR 
(400 MHz, DMSO-d6): δ (ppm) = 13.99 (s, 1H, NHC–O), 8.71 (d, 2H, J 
= 4.4 Hz, H-2, H-6), 7.73 (d, 2H, J = 4.4 Hz, H-3, H-5), 5.29 (s, 1H, 
NHCH2), 2.78 (m, 2H, H-1′), 1.44 (m, 2H, H-2′), 1.31 (m, 6H, H-3′, H-4′, 
H-5′), 0.86 (t, 3H, H-6′); 13C NMR (100.6 MHz, DMSO-d6): δ (ppm) 
= 163.49 (C–O), 150.26 (C-2, C-6), 140.24 (C-4), 121.09 (C-3, C-5), 
51.01 (C-1′), 31.24 (C-4′), 27.58 (C-2′), 26.34 (C-3′), 22.13 (C-5′), 13.99 
(C-6′). HR-ESI-MS: m/z 222.1602 [M + H]+ (calcd. for C12H19N3O + H, 
222.1601). 
5.3.2. N′-octylisonicotinohydrazide 3d 
Amorphous white powder (column chromatography with Et2O: 
MeOH 98.2) η = 47.3%; IR (KBr): ν (cm− 1) = 3265 (N–H amide), 3018 
(arom. C–H), 2925–2871 (aliph. C–H), 1636 (C–O amide); 1H NMR 
(400 MHz, DMSO-d6): δ (ppm) = 10.29 (s, 1H, NHC–O), 8.70 (d, 2H, J 
= 4.4 Hz, H-2, H-6), 7.72 (d, 2H, J = 4.4 Hz, H-3, H-5), 5.25 (s, 1H, 
NHCH2), 2.78 (m, 2H, H-1′), 1.44 (m, 2H, H-2′), 1.27 (m, 10H, H-3′ to H- 
7′), 0.85 (t, 3H, H-8′); 13C NMR (100.6 MHz, DMSO-d6): δ (ppm) 
= 163.45 (C–O), 150.24 (C-2, C-6), 140.21 (C-4), 121.06 (C-3, C-5), 
50.96 (C-1′), 31.28 (C-6′), 28.94, 28.70 (C-4′, C-5′), 27.58 (C-2′), 26.64 
(C-3′), 22.12 (C-7′), 13.99 (C-8′). HR-ESI-MS: m/z 250.1921 [M + H]+
(calcd. for C14H23N3O + H, 250.1914). 
5.3.3. N′-decylisonicotinohydrazide 3e 
Amorphous white powder (column chromatography with AcOEt: 
MeOH 45:1) η = 32.9%; IR (KBr): ν (cm− 1) = 3330 (N–H amine), 3272 
(N–H amide), 3028 (arom. C–H), 2917–2846 (aliph. C–H), 1640 
(C–O amide); 1H NMR (400 MHz, DMSO-d6): δ (ppm) = 10.30 (s, 1H, 
NHC–O), 8.70 (d, 2H, J = 4.4 Hz, H-2, H-6), 7.72 (d, 2H, J = 4.4 Hz, H- 
3, H-5), 5.25 (s, 1H, NHCH2), 2.77 (m, 2H, H-1′), 1.44 (m, 2H, H-2′), 
1.23 (m, 14H, H-3′ to H-9′), 0.84 (t, 3H, J = 6.0 Hz, H-10′) 13C NMR 
(100.6 MHz, DMSO-d6): δ (ppm) = 163.43 (C–O), 150.22 (C-2, C-6), 
140.19 (C-4), 121.04 (C-3, C-5), 50.96 (C-1′), 31.30 (C-8′), 29.03, 28.99, 
28.96, 28.73 (C-4′ to C-7′), 27.57 (C-2′), 26.63 (C-3′), 22.11 (C-9′), 13.97 
(C-10′). HR-ESI-MS: m/z 278.2235 [M + H]+ (calcd. for C16H27N3O + H, 
278.2227). 
5.4. Stability evaluation by ultraperformance liquid chromatography- 
tandem mass spectrometry (UPLC-MS/MS) 
Water stability of compound 2c was accessed using an Elute ultra- 
high performance liquid chromatography system (Bruker, Bremen, 
Germany), equipped with a thermostatted autosampler, and interfaced 
with an ultra-high resolution quadrupole time-of-flight Impact II QTOF 
(Bruker, Bremen, Germany). Separations were performed on an in-
tensity Solo 2 C18 RP column (100 × 2.1 mm, 2 μm; Bruker, Bremen, 
Germany) using a gradient of 0.1% (v/v) aqueous solution of formic acid 
(eluent A) and 0.1% (v/v) solution of formic acid in acetonitrile (eluent 
B), as follows: 0 min - 95% A; 1.5 min – 95% A; 13.5 min – 25% A; 
18.5 min – 0% A; 21.5 min – 0% A; 23.5 min – 95% A; 30 min – 95% A. 
The column was then washed with 100% of eluent B for 5 min and 
reconditioned to initial conditions. The injection volume was set at 5 μL, 
the column was thermostatted at 35 ◦C and the flow rate was set at 
0.250 mL/min. Spectral data were recorded in the m/z 50–1500 range. 
Electro-spray ionization in positive mode (4000 V capillary voltage, 
6.0 mL drying gas flow at 200 ◦C, 10.0 eV collision cell energy) was used 
and MS/MS monitoring was chosen for detection. The internal standard 
solution was prepared, mixing 250 mL H2O, 250 mL isopropyl alcohol 
(i-PrOH), 750 μL acetic acid, 250 μL formic acid and 0.5 mL 1 M NaOH 
solution. Data acquisition was carried out using the software Compass 
Data Analysis v.4.4 from Bruker. A solution of this compound (2c) at a 
concentration of 2.28 × 10− 4 M was prepared by ultrasound-assisted 
dissolution at room temperature of 0.5 mg in 10 mL of MilliQ water. 
5 μL of the sample solution was injected after 5 min of the beginning of 
dissolution. UPLC-MS chromatograms were acquired at 60, 120, 240 
and 1200 min after the first injection. 
5.5. In vitro kinetic assays 
The KatG-dependent activation of isoniazid, as well as its hydrazide 
and hydrazone derivatives, was evaluated by monitoring radical for-
mation. The radical formation was determined by monitoring the con-
version of nitroblue tetrazolium (NBT) to its corresponding formazan at 
560 nm (ϵ = 18,500 M− 1 cm− 1) for 600 s in a solution with 1.25 μM 
KatG, 0.2 mM NBT, 0.2 μM MnCl2, and 1.0 mM isoniazid or isoniazid 
derivative. All assays were carried out in 50% DMSO and 50 mM Tris- 
HCl, pH 8.0 at room temperature, and collected on a Shimadzu UV-Vis 
spectrophotometer. Results include two repeated experiments each 
with triplicate measurements. MnCl2 and KatG-negative controls were 
included for each compound tested. Initial rates of NBT conversion to 
formazan were determined within the 35–40–100 s time window. The 
first 35–40 s of the raw traces contain features that are consistent with 
mixing artifacts and are therefore not included in the fitting and are 
represented by thin dotted lines (Fig. 3). The stimulatory effect of KatG 
was determined for NBT formazan formation by dividing the rates ob-
tained with KatG by those obtained without. 
5.6. Cytotoxicity towards HepG2 Cells 
The in vitro toxicity of the studied compounds was evaluated using 
HepG2 cells, a human liver cancer cell line. HepG2 cells were plated on 
384-well tissue culture-treated polystyrene plates at 2000 cells in 25 μL 
of HepG2 maintenance medium per well. After overnight incubation at 
37 ◦C, the cells were dosed with test compounds and controls solubilized 
in dimethyl sulfoxide (DMSO) at a range of concentrations (dependent 
on the compound) and incubated for 72 h at 37 ◦C. The aqueous solu-
bility of the compounds determined the range of concentrations tested. 
All compounds were solubilized in DMSO to 200-fold of the final top 
testing concentration. If compounds were soluble in DMSO (as for INH, 
INH-iC4, INH-iC6, INH-aC6, INH-aC8), aqueous solubility was tested 
using the medium at the top testing concentration (in these cases 
200 μM) in a clear-bottom 96-well plate. For INH-C10, INH-iC8, INH- 
iC10, and INH-aC10 the top testing concentration was 25, 100, 25, and 
100 μM, respectively. Visual inspection was performed under a micro-
scope for the identification of any precipitate. If precipitation was 
observed, DMSO volume in stock solution was doubled until acceptable 
aqueous solubility was found. 
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Cell viability was measured using the Promega CellTiter 96 Non- 
Radioactive Cell Proliferation Assay (MTT [44]) kit by adding the dye 
solution to each well and incubating for 3 h at 37 ◦C. After incubation, 
the solubilization solution/stop mix was added to each well. Plates were 
incubated at 37 ◦C for 1 h, mixed on a plate shaker for 10 min, and then 
absorbance read at 570 nm. Three independent replicates were per-
formed for each compound concentration. 
The concentration corresponding to 50% inhibition of cell viability, 
IC50, was calculated with GraphPad Prism using a sigmoidal dose- 
response (variable slope) algorithm (see Fig. S19 of Supplementary 
material). Chlorpromazine, a well-known potent antipsychotic drug, 
was used as the positive control (IC50 = 13.9 μM). 
5.7. Lipophilicity evaluation in terms of log Po/w 
Lipophilicity was assessed as the octanol-water partition coefficient 
(log Po/w) determined by the shake-flask method, using the same pro-
cedure as previously described [32,42]. For both INH-iC6 and INH-iC10, 
samples were dissolved in water-saturated octanol at pH 6.4 
(KH2PO4/NaOH buffer) to ensure negligible ionization. The partition to 
octanol-saturated aqueous buffer was measured, at room temperature, 
using a volume ratio, ro/w, of 5/30 and 10/30, after 10 min sonication 
and 3 h partition on an in-house built mechanical tumbler. Equilibrium 
concentration was obtained by UV–Vis spectrophotometry between 200 
and 500 nm after phase separation (5 min centrifugation). 
5.8. Microbiology studies 
Primary cultures: Mtb H37Rv was inoculated in mycobacteria growth 
indicator tubes (MGIT; Becton Dickinson, Sparks, MD, USA) supple-
mented with 10% OADC. The OADC supplement (from Becton Dick-
inson) contains oleic acid, bovine albumin, dextrose, and catalase. Oleic 
acid and other long-chain fatty acids are essential for mycobacteria 
metabolism, while dextrose is an energy source. Catalase neutralizes 
toxic peroxides and albumin also protects the mycobacteria from several 
toxic agents. The final tubes were incubated at 37 ◦C in the BACTEC 
MGIT 960 (MGIT 960; Becton Dickinson) system until they reached 
100–200 growth units (GUs) and used directly for testing. Cultures with 
200 > GU < 2000 were diluted to 100–200 GU with a sterile saline so-
lution and used for testing. Growth of the cultures was monitored with 
the Epicenter V5.80A software equipped with the TB eXIST module 
(Becton Dickinson). 
MIC and MBC determination: the MGITs were inoculated with 
0.8 mL of OADC, 0.1 mL of the compound at the desired concentration 
and 0.5 mL of the suspension of the strain. The compounds were pre-
pared at two-fold serial dilutions to obtain concentrations ranging from 
0.03125 to 128 μM. For preparation of the drug-free proportional con-
trol, the primary culture was diluted 1:100 with a sterile saline solution 
and 0.5 mL inoculated in the tube. The drug-free absolute control was 
inoculated with 0.5 mL of the undiluted culture. The drug-containing 
tubes with > 100 GU when the proportional control reached 400 GU 
were resistant to the corresponding concentration. If the GU of the tube 
containing the drug was < 100 GU they were susceptible. The minimum 
bactericidal concentration (MBC) was determined with the MGIT 960 
and defined as the concentration that prevents Mtb growth after 100 
days of incubation at 37 ◦C [45]. 
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Fig. 3. Nitroblue tetrazolium (NBT) conversion to formazan by representative 
INH derivatives in the presence (top) and absence (bottom) of KatG. Isoniazid 
(INH), the hydrazide C8 (INH-aC8; 3d) and C10 (INH-aC10; 3e) derivatives, and 
the hydrazone C4 (INH-iC4; 2b) and C10 (INH-iC10; 2e) derivatives, each at 
1.0 mM, were reacted in the presence of 0.2 μM MnCl2 and 1.25 μM KatG. Each 
trace is the average of two experiments, each of which contained three repli-
cates. Initial rates were determined 30–40 s after initiation of reactions in order 
to minimize interference from initial mixing phenomena. All reactions were 
carried out in 50 mM Tris-HCl and 50% DMSO, pH 8 at room temperature. 
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Appendix A. Supplementary material 
Supplementary data associated with this article can be found in the 
online version at doi:10.1016/j.biopha.2021.112362. 
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